A Novel microRNAs Expression Signature for Hepatocellular Carcinoma Diagnosis and Prognosis

Oncotarget - United States
doi 10.18632/oncotarget.14452
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

MicroRNAs: New Tools for Diagnosis, Prognosis, and Therapy in Hepatocellular Carcinoma?

Hepatology
MedicineHepatology
2012English

Exosomal miR-665 as a Novel Minimally Invasive Biomarker for Hepatocellular Carcinoma Diagnosis and Prognosis

Oncotarget
Oncology
2017English

A Novel Prognostic Scoring Model Based on Albumin and Γ-Glutamyltransferase for Hepatocellular Carcinoma Prognosis

Cancer Management and Research
Oncology
2019English

Relationship Between Survivin Expression and Recurrence, and Prognosis in Hepatocellular Carcinoma

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Breast Carcinoma With Amplified HER2: A Gene Expression Signature Specific for Trastuzumab Resistance and Poor Prognosis

Modern Pathology
Forensic MedicinePathology
2010English

Expression of P-Glycoprotein in Hepatocellular Carcinoma: A Potential Marker of Prognosis.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1996English

ASPM Is a Novel Marker for Vascular Invasion, Early Recurrence, and Poor Prognosis of Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Correlation of PDK1 Expression With Clinicopathologic Features and Prognosis of Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

CELSR3 mRNA Expression Is Increased in Hepatocellular Carcinoma and Indicates Poor Prognosis

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy